Study title: Open Randomized Parallel Group Design Trial Investigating the Efficacy and Tolerability of Beclomethasone Dipropionate (100 mcg qid) Dry Powder Delivered from Two Different Powder Inhalers (Chiesi and Glaxo) in the Treatment of Chronic Asthma in ChildrenJOURNAL OF AEROSOL MEDICINE, Volume 13, Number 1, 2000
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: please see report | |||||
MAH holders: please see report | |||||
Assessment: | |||||
Active substance: BECLAMETHASONE | |||||
ATC code: | |||||
Document link: 15.02-CT-92-Pubblication.pdf | |||||
Document date: 2015-03-02 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |